Ibritumomab, known as Zevalin, represents a innovative form of targeted radiotherapy used to combat certain forms of non-Hodgkin's lymphoma , particularly relapsed follicular lymphoma . This is a monoclonal https://www.targetmol.com/compound/ibritumomab